| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0084 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.0077 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.0077 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0075 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |